Press release
Investigation announced for Long-Term Investors in Provention Bio, Inc. (NASDAQ: PRVB) shares

An investigation on behalf of current long term investors in Provention Bio, Inc. (NASDAQ: PRVB) shares.
Investors who are current long term investors in Provention Bio, Inc. (NASDAQ: PRVB) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: PRVB stocks follows a lawsuit filed against Provention Bio, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: PRVB stocks, concerns whether certain Provention Bio, Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges that, the defendants made false and/or misleading statements and/or failed to disclose that the teplizumab BLA was deficient in its submitted form and would require additional data to secure FDA approval, that accordingly, the teplizumab BLA lacked the evidentiary support the Company had led investors to believe it possessed, that the Company had thus overstated the teplizumab BLA's approval prospects and hence the commercialization timeline for teplizumab, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Provention Bio, Inc. (NASDAQ: PRVB) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in Provention Bio, Inc. (NASDAQ: PRVB) shares here
News-ID: 2394820 • Views: …
More Releases from Shareholders Foundation
Ardent Health, Inc. (NYSE: ARDT) Investor Alert: Deadline in Lawsuit on March 09 …
A deadline is coming up on March 09, 2026 in the lawsuit filed for certain investors of Ardent Health, Inc. (NYSE: ARDT) over alleged securities laws violations by Ardent Health, Inc.
Investors who purchased shares of Ardent Health, Inc. (NYSE: ARDT) have certain options and there are strict and short deadlines running. Deadline: March 09, 2026. Ardent Health, Inc. (NYSE: ARDT) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or…
Sina Corporation (formerly NASDAQ: SINA) Investor Alert: Investigation of potent …
An investigation on behalf of investors in shares of Sina Corporation (formerly NASDAQ: SINA) concerning potential breaches of fiduciary duties by certain directors and officers was announced.
Investors who are current long term investors inSina Corporation (formerly NASDAQ: SINA shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in Sina Corporation (formerly NASDAQ:…
Lawsuit DEADLINE Alert: Investors who lost money with Stride, Inc. (NYSE: LRN) s …
An investor, who purchased shares of Stride, Inc. (NYSE: LRN), filed a lawsuit over alleged violations of Federal Securities Laws by Stride, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Stride, Inc. (NYSE: LRN) have certain options and for certain investors are short and strict deadlines running. Deadline: January 12, 2026. NYSE: LRN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
More Releases for Provention
Bispecific Antibody Competitive Landscape Report 2025 | Janssen, Amgen, Akeso, Z …
DelveInsight's, "Bispecific antibody - Competitive landscape, 2025," report provides comprehensive insights about 180+ companies and 250+ drugs in Bispecific antibody Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Bispecific Antibody Competitive Landscape Report
• DelveInsight's Bispecific Antibody report depicts a robust space with 180+ active players working to develop 250+…
Gluten Sensitivity Market to Rise by 2032 | 9 Meters Biopharma, ImmunogenX, Prov …
DelveInsight's "Gluten Sensitivity Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Gluten Sensitivity, historical and forecasted epidemiology as well as the Gluten Sensitivity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Gluten Sensitivity market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Gluten Sensitivity market size…
Bispecific Antibody Competitive Landscape Report 2024 (Updated) | Janssen, Amgen …
DelveInsight's, "Bispecific antibody Competitive landscape 2024" report provides comprehensive insights about 250+ Bispecific Antibody companies and 300+ Bispecific Antibody drugs in Bispecific antibody Competitive landscape. It covers the Bispecific Antibody therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Bispecific Antibody Competitive Landscape Report
• DelveInsight's Bispecific Antibody report depicts a robust space with 250+…
Bispecific Antibody Competitive Landscape Report (Updated) | Janssen, Amgen, Ake …
DelveInsight's, "Bispecific antibody Competitive landscape" report provides comprehensive insights about 250+ Bispecific Antibody companies and 300+ Bispecific Antibody drugs in Bispecific antibody Competitive landscape. It covers the Bispecific Antibody therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Bispecific Antibody Competitive Landscape Report
• DelveInsight's Bispecific Antibody report depicts a robust space with 250+ active…
Gluten Sensitivity Market to Witness Growth by 2032 | 9 Meters Biopharma, Immuno …
DelveInsight's "Gluten Sensitivity Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Gluten Sensitivity, historical and forecasted epidemiology as well as the Gluten Sensitivity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Gluten Sensitivity market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Gluten Sensitivity market size…
Deadline on July 20th coming up ion Lawsuit for Investors in Provention Bio, Inc …
A deadline is coming up on July 20, 2021 in the lawsuit filed for certain investors of Provention Bio, Inc. (NASDAQ: PRVB) over alleged securities laws violations by Provention Bio, Inc.
Investors who purchased shares of Provention Bio, Inc. (NASDAQ: PRVB) have certain options and there are strict and short deadlines running. Deadline: July 20, 2021. NASDAQ: PRVB stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…